Smith-Lemli-Opitz syndrome: deficient delta 7-reductase activity in cultured skin fibroblasts and chorionic villus fibroblasts and its application to pre- and postnatal detection.

作者: R. J. A. Wanders , G. J. Romeijn , F. Wijburg , R. C. M. Hennekam , J. de Jong

DOI: 10.1023/A:1005371104822

关键词:

摘要: The Smith-Lemli-Opitz syndrome (SLO) is a recently identified disorder of cholesterol biosynthesis, clinically characterized by typical facial dysmorphia including microcephaly, ptosis, cataracts, anteverted nares, low-set posteriorly rotated ears and micrognathia, multiple congenital limb organ anomalies severe mental retardation with incomplete myelination the brain peripheral nerves (Smith et al 1964). In 1993, Irons coworkers (1993) reported marked elevation 7-dehydrocholesterol in patients SLO, suggesting defect penultimate step biosynthesis (Tint 1994). This was established experimentally same group investigators, who deficient Δ 7 -reductase activity microsomes prepared from liver specimens obtained four SLO homozygotes (Shafer 1995). These experiments were followed studies cultured skin fibroblasts using radiolabelled lathosterol as more stable precursor (Honda Similar performed Lund (1996) also [ 3 H]lathosterol. this paper we describe simple method allowing direct measurement chorionic villus which now commercially available.

参考文章(10)
G Stephen Tint, Mira Irons, Ellen Roy Elias, Ashok K. Batta, Roger Frieden, Thomas S. Chen, Gerald Salen, Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. The New England Journal of Medicine. ,vol. 330, pp. 107- 113 ,(1994) , 10.1056/NEJM199401133300205
E. MALLE, K. OETTL, W. SATTLER, G. HOEFLER, G. M. KOSTNER, Cholesterol biosynthesis in dermal fibroblasts from patients with metabolic disorders of peroxisomal origin European Journal of Clinical Investigation. ,vol. 25, pp. 59- 67 ,(1995) , 10.1111/J.1365-2362.1995.TB01527.X
Kevin Mills, Hanna Mandel, Rodolfo Montemagno, Peter Soothill, R Gershoni-Baruch, Peter T Clayton, First trimester prenatal diagnosis of Smith-Lemli-Opitz syndrome (7-dehydrocholesterol reductase deficiency). Pediatric Research. ,vol. 39, pp. 816- 819 ,(1996) , 10.1203/00006450-199605000-00012
Johannes Aufenanger, Johannes Pill, Felix H. Schmidt, Karlheinz Stegmeier, The effects of BM 15.766, an inhibitor of 7-dehydrocholesterol δ7-reductase∗, on cholesterol biosynthesis in primary rat hepatocytes Biochemical Pharmacology. ,vol. 35, pp. 911- 916 ,(1986) , 10.1016/0006-2952(86)90076-6
Mira Irons, Ellen Roy Elias, Gerald Salen, G.S. Tint, AshokK. Batta, Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. The Lancet. ,vol. 341, pp. 1414- 1414 ,(1993) , 10.1016/0140-6736(93)90983-N
J. Pill, F. Schmidt, K. Stegmeier, E.-C. Witte, Effects of BM 15.766 on serum lipids in rats Hormone and Metabolic Research. ,vol. 17, pp. 543- 544 ,(1985) , 10.1055/S-2007-1013600
S Shefer, G Salen, A K Batta, A Honda, G S Tint, M Irons, E R Elias, T C Chen, M F Holick, Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes. Journal of Clinical Investigation. ,vol. 96, pp. 1779- 1785 ,(1995) , 10.1172/JCI118223
David W. Smith, Luc Lemli, John M. Opitz, A newly recognized syndromeof multiple congenital anomalies The Journal of Pediatrics. ,vol. 64, pp. 210- 217 ,(1964) , 10.1016/S0022-3476(64)80264-X
A Honda, G S Tint, G Salen, A K Batta, T S Chen, S Shefer, Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes. Journal of Lipid Research. ,vol. 36, pp. 1595- 1601 ,(1995) , 10.1016/S0022-2275(20)39745-5